Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Apr 20;18(4):e0284057.
doi: 10.1371/journal.pone.0284057. eCollection 2023.

Omega-3 supplements in the prevention and treatment of youth depression and anxiety symptoms: A scoping review

Natalie M Reily  1 , Samantha Tang  1 , Ashlee Negrone  1 , Daniel Z Q Gan  1 , Veronica Sheanoda  1 , Helen Christensen  1
Affiliations

Omega-3 supplements in the prevention and treatment of youth depression and anxiety symptoms: A scoping review

Natalie M Reily et al. PLoS One. .

Abstract

Introduction: Omega-3 supplements may be efficacious in reducing symptoms of depression and anxiety in adults, particularly as an adjunct to antidepressant medication. However, research in young people is limited. Thus, this scoping review aimed to summarise existing evidence on the efficacy of omega-3 supplementation in treating depression and anxiety symptoms in young people aged 14-24. A secondary aim was to determine whether grey literature intended for the general public accurately reflects the evidence.

Method: Four databases (Cochrane CENTRAL, EmBASE, PsycINFO, PubMed) were searched from inception to 4th August 2021. Eligible peer-reviewed studies were empirical studies which examined the efficacy of omega-3 supplements in preventing/treating anxiety and/or depression symptoms in young people aged 14-24. Risk of bias was assessed for randomised studies using the Cochrane Risk of Bias Tool. Selected grey literature databases were also searched, with eligible sources assessed for quality. A stakeholder group including young people with lived experience of anxiety/depression, parents/carers and mental health professionals informed the research questions and data interpretation. Findings were summarised using narrative synthesis.

Results: 17 empirical studies (N = 1240 participants) meeting inclusion criteria were identified. Studies varied in treatment and participant characteristics. In general, the data did not support the view that omega-3 supplements were efficacious in improving symptoms of anxiety or depression in young people aged 14-24. In contrast, most grey literature sources recommended the use of omega-3 supplements in young people.

Discussion: Evidence for efficacy of omega-3 supplementation in reducing symptoms of depression and anxiety in young people was inconclusive. More research is needed to identify potential mechanisms and moderators of the effect of omega-3 supplements on depression and anxiety symptoms in young people.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig 1
Fig 1. PRISMA flow diagram: Scientific literature screening process.
Fig 2
Fig 2. PRISMA flow diagram: Grey literature screening process.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Kessler RC, Berglund P, Demler O, Jin R, Merikangas KR, Walters EE. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005;62(6):593–602. doi: 10.1001/archpsyc.62.6.593 - DOI - PubMed
    1. Teesson M, Slade T, Mills K. Comorbidity in Australia: Findings of the 2007 National Survey of Mental Health and Wellbeing. Australian & New Zealand Journal of Psychiatry. 2009;43(7):606–14. doi: 10.1080/00048670902970908 - DOI - PubMed
    1. Zhou X, Teng T, Zhang Y, Del Giovane C, Furukawa TA, Weisz JR, et al.. Comparative efficacy and acceptability of antidepressants, psychotherapies, and their combination for acute treatment of children and adolescents with depressive disorder: a systematic review and network meta-analysis. The Lancet Psychiatry. 2020;7(7):581–601. doi: 10.1016/S2215-0366(20)30137-1 - DOI - PMC - PubMed
    1. Zhou X, Zhang Y, Furukawa TA, Cuijpers P, Pu J, Weisz JR, et al.. Different types and acceptability of psychotherapies for acute anxiety disorders in children and adolescents: A network meta-analysis. JAMA Psychiatry. 2019;76(1):41–50. doi: 10.1001/jamapsychiatry.2018.3070 - DOI - PMC - PubMed
    1. Cuijpers P, Cristea IA, Karyotaki E, Reijnders M, Huibers MJH. How effective are cognitive behavior therapies for major depression and anxiety disorders? A meta-analytic update of the evidence. World Psychiatry. 2016;15(3):245–58. doi: 10.1002/wps.20346 - DOI - PMC - PubMed

Publication types

Substances